Kurie JM - Search Results

1

EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer.

Xiao GY, Tan X, Rodriguez BL, Gibbons DL, Wang S, Wu C, Liu X, Yu J, Vasquez ME, Tran HT, Xu J, Russell WK, Haymaker C, Lee Y, Zhang J, Solis L, Wistuba II, Kurie JM. Xiao GY, et al. Among authors: kurie jm. Proc Natl Acad Sci U S A. 2023 Jul 11;120(28):e2220276120. doi: 10.1073/pnas.2220276120. Epub 2023 Jul 5. Proc Natl Acad Sci U S A. 2023. PMID: 37406091 Free PMC article.

2

Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras.

Wislez M, Spencer ML, Izzo JG, Juroske DM, Balhara K, Cody DD, Price RE, Hittelman WN, Wistuba II, Kurie JM. Wislez M, et al. Among authors: kurie jm. Cancer Res. 2005 Apr 15;65(8):3226-35. doi: 10.1158/0008-5472.CAN-04-4420. Cancer Res. 2005. PMID: 15833854

3

High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor.

Fujimoto N, Wislez M, Zhang J, Iwanaga K, Dackor J, Hanna AE, Kalyankrishna S, Cody DD, Price RE, Sato M, Shay JW, Minna JD, Peyton M, Tang X, Massarelli E, Herbst R, Threadgill DW, Wistuba II, Kurie JM. Fujimoto N, et al. Among authors: kurie jm. Cancer Res. 2005 Dec 15;65(24):11478-85. doi: 10.1158/0008-5472.CAN-05-1977. Cancer Res. 2005. PMID: 16357156

4

High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras.

Wislez M, Fujimoto N, Izzo JG, Hanna AE, Cody DD, Langley RR, Tang H, Burdick MD, Sato M, Minna JD, Mao L, Wistuba I, Strieter RM, Kurie JM. Wislez M, et al. Among authors: kurie jm. Cancer Res. 2006 Apr 15;66(8):4198-207. doi: 10.1158/0008-5472.CAN-05-3842. Cancer Res. 2006. PMID: 16618742

5

c-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells.

Khatlani TS, Wislez M, Sun M, Srinivas H, Iwanaga K, Ma L, Hanna AE, Liu D, Girard L, Kim YH, Pollack JR, Minna JD, Wistuba II, Kurie JM. Khatlani TS, et al. Among authors: kurie jm. Oncogene. 2007 Apr 19;26(18):2658-66. doi: 10.1038/sj.onc.1210050. Epub 2006 Oct 23. Oncogene. 2007. PMID: 17057737

6

Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway.

Xia D, Srinivas H, Ahn YH, Sethi G, Sheng X, Yung WK, Xia Q, Chiao PJ, Kim H, Brown PH, Wistuba II, Aggarwal BB, Kurie JM. Xia D, et al. Among authors: kurie jm. J Biol Chem. 2007 Feb 9;282(6):3507-19. doi: 10.1074/jbc.M610141200. Epub 2006 Dec 11. J Biol Chem. 2007. PMID: 17158870 Free article.

7

SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines.

Zhang J, Kalyankrishna S, Wislez M, Thilaganathan N, Saigal B, Wei W, Ma L, Wistuba II, Johnson FM, Kurie JM. Zhang J, et al. Among authors: kurie jm. Am J Pathol. 2007 Jan;170(1):366-76. doi: 10.2353/ajpath.2007.060706. Am J Pathol. 2007. PMID: 17200208 Free PMC article.

8

Lung premalignancy induced by mutant B-Raf, what is thy fate? To senesce or not to senesce, that is the question.

Haigis KM, Wistuba II, Kurie JM. Haigis KM, et al. Among authors: kurie jm. Genes Dev. 2007 Feb 15;21(4):361-6. doi: 10.1101/gad.1532107. Genes Dev. 2007. PMID: 17322395 Free article. No abstract available.

9

Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer.

Iwanaga K, Yang Y, Raso MG, Ma L, Hanna AE, Thilaganathan N, Moghaddam S, Evans CM, Li H, Cai WW, Sato M, Minna JD, Wu H, Creighton CJ, Demayo FJ, Wistuba II, Kurie JM. Iwanaga K, et al. Among authors: kurie jm. Cancer Res. 2008 Feb 15;68(4):1119-27. doi: 10.1158/0008-5472.CAN-07-3117. Cancer Res. 2008. PMID: 18281487 Free PMC article.

10

A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras.

Yang Y, Wislez M, Fujimoto N, Prudkin L, Izzo JG, Uno F, Ji L, Hanna AE, Langley RR, Liu D, Johnson FM, Wistuba I, Kurie JM. Yang Y, et al. Among authors: kurie jm. Mol Cancer Ther. 2008 Apr;7(4):952-60. doi: 10.1158/1535-7163.MCT-07-2045. Mol Cancer Ther. 2008. PMID: 18413809 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page